XML 48 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Leases (Tables)
 3 Months Ended
Mar. 31, 2026
Leases [Abstract]  
Schedule of Lease, Cost The components of the Company’s lease expense are as follows:
Three Months Ended
March 31,
20262025
Operating lease expense$4,091 $3,708 
Short-term lease expense222 144 
Supplemental cash flow information related to the Company’s leases is as follows:
Three Months Ended
March 31,
20262025
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$4,047 $3,584 
Non-cash lease liabilities activity:
Leased assets obtained in exchange for new operating lease liabilities4,078 3,877 
Supplemental balance sheet information related to the Company’s leases is as follows:
March 31,
2026		December 31,
2025
Right-of-use lease assets$38,534 $38,737 
Other accrued liabilities12,854 12,536 
Long-term lease liabilities22,134 22,759 
Total operating lease liabilities$34,988 $35,295 
Weighted average remaining lease term (years)5.55.7
Weighted average discount rate6.65 %6.58 %
Schedule of Lessee, Operating Lease, Liability, Maturity
Maturities of operating lease liabilities as of March 31, 2026 were as follows:
For the remainder of 2026$11,303 
For the year ended December 31, 202710,462 
For the year ended December 31, 20287,393 
For the year ended December 31, 20294,373 
For the year ended December 31, 20302,328 
For the year ended December 31, 2031 and beyond7,814 
  Total lease payments43,673 
    Less: imputed interest(8,685)
Present value of lease liabilities (1)
$34,988 
(1) During the year ended December 31, 2024, the Company entered into a new lease agreement for office and laboratory space in Radnor, Pennsylvania for the purpose of relocating its global headquarters. The lease for one portion of the laboratory space is expected to commence in the second quarter of 2026. The lease for the remaining portions of laboratory and office space is expected to commence upon the completion of the lessor owned leasehold improvements, which is expected to be in the fourth quarter of 2026 or the first quarter of 2027. The cumulative future lease commitment for the laboratory and office space is $79.7 million. The future lease commitments relating to this lease were not included in the lease liabilities balance as of March 31, 2026.